ResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05 - RMD News | RalliesResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05
R
RMD• ResMed CEO reports share sale after option exercise
- ResMed Chairman and CEO Michael J. Farrell sold 4,991 shares on Aug. 7 at $205.69 each.
- The sale followed the exercise of 4,991 stock options at $146.34.
- Direct holdings fell to 466,256 shares.
- He also reported 14,975 options remaining.
•
